— Know what they know.
Not Investment Advice
Also trades as: GOVXW (NASDAQ) · $vol 0M

GOVX NASDAQ

GeoVax Labs, Inc.
1W: -6.5% 1M: -40.6% 3M: -73.8% YTD: -93.7% 1Y: -97.6% 3Y: -99.8% 5Y: -100.0%
$0.32
-0.00 (-0.65%)
 
Weekly Expected Move ±6.9%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 24 · $2.4M mcap · 7M float · 70.90% daily turnover · Short 40% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$4M +0.0% ▲
5Y CAGR: +27.5%
Gross Profit
$4M +118.6% ▲
5Y CAGR: +26.8%
Operating Income
-$25M +6.0% ▲
Net Income
-$25M +3.8% ▲
EPS (Diluted)
$-4.82 +52.8% ▲
EBITDA
-$25M +6.7% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$2M$386K$82K$0$4M
YoY Growth+55.0%-78.9%-79.0%-100.0%+0.0%
Cost of Revenue$0$0$9M$21M$95K
Gross Profit$2M$386K-$9M-$21M$4M
Gross Margin100.0%100.0%-11090.9%—97.6%
R&D Expenses$2M$16M$9M$21M$24M
SG&A Expenses$2M$4M$5M$6M$5M
Operating Expenses$5M$19M$5M$6M$29M
Operating Income-$3M-$19M-$14M-$27M-$25M
Operating Margin-154.5%-4862.7%-17207.5%—-635.8%
Interest Expense$144K$1K$0$0$21K
Income Before Tax-$3M-$19M-$14M-$26M-$25M
Tax Expense$0$0$0$0$0
Net Income-$3M-$19M-$14M-$26M-$25M
Net Margin-162.2%-4817.2%-17198.3%—-632.0%
EPS (Diluted)$-1.16$-7.30$-5.52$-10.22$-4.82
EBITDA-$3M-$19M-$14M-$27M-$25M
Shares Outstanding3M3M3M3M5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms